● Recruiting

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

Condition: Carcinoma, Hepatocellular · Hepatitis C, Chronic · Hepatitis B, Chronic · Sponsor: Ruijin Hospital

PhaseN/A

Planned participants20000

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

The goal of this study is to evaluate whether the standardized liver cancer risk stratification management can effectively improve the early diagnosis rate of liver cancer in the targeted risk population in China.

This description comes directly from the study's public registry record.

Talk to the study team

Qing Xie, MD · 0086-021-64370045 · xieqingrjh@163.com

Honglian Gui, MD,PhD · 0086-021-64370045 · lillian_ghl@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Infectious Diseases , Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05870969